NATCO Pharma Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 7,586 million compared to INR 4,925 million a year ago. Revenue was INR 7,956 million compared to INR 5,133 million a year ago. Net income was INR 2,127 million compared to INR 623 million a year ago. Basic earnings per share from continuing operations was INR 11.88 compared to INR 3.41 a year ago. Diluted earnings per share from continuing operations was INR 11.88 compared to INR 3.41 a year ago.
For the nine months, sales was INR 29,305 million compared to INR 18,092 million a year ago. Revenue was INR 30,166 million compared to INR 18,848 million a year ago. Net income was INR 10,020 million compared to INR 4,395 million a year ago. Basic earnings per share from continuing operations was INR 55.78 compared to INR 24.08 a year ago. Diluted earnings per share from continuing operations was INR 55.78 compared to INR 24.08 a year ago.